MedTrace Logo

Effect of BIBW 2948 BS in COPD

NCT00423137 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-11-19

Study results available
· View outcomes & findings →

Summary

Study of BIBW 2948 BS in Patients with COPD and Chronic Bronchitis

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Bronchitis, Chronic

Interventions

DRUG

BIBW 2948 BS

Capsule

DRUG

Placebo

Capsule

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-17
Primary Completion
2008-07-09
Completion
2008-07-09

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00423137 on ClinicalTrials.gov